Acquisition Announced Sponsor buyer
Celadon Partners SPV 35 acquisition of Senti Holdings, Inc. (Midco)
Announced 14 Jul 2026
Advisers
Senti Holdings, Inc. (Midco)
Target
- Financial adviser
- Legal adviser
- Fairness opinion
- Target
- Senti Holdings, Inc. (Midco)
- Acquirer
- Celadon Partners SPV 35
- Seller
- Senti Biosciences Holdings
- Target based in
- United States
- Seller based in
- United States
- Sector
- Biotech
- Tags
- Biotech, Cell Therapy, Drug Development
In the league tables
Similar deals
- Leyden Labs acquisition of RIGImmune Sep 2026 · Biotech
- GSK acquisition of trispecific T cell-engager (TCE) asset Sep 2026 · US$750m · Biotech
- Novo Nordisk stake in Orbis Medicines Sep 2026 · Biotech
- Eli Lilly and Company acquisition of Merida Biosciences Aug 2026 · US$2.9bn · Biotech
- Werewolf Therapeutics and Ambros Therapeutics merger Aug 2026 · US$500m · Biotech
Sources
- 24 Sep 2026 Definitive merger proxy statement (DEFM14A), Senti Biosciences Holdings, Inc. sec.gov